Mark Cushman, Purdue University and Gibson Oncology (IMAGE)

Purdue University

Mark Cushman, Purdue University and Gibson Oncology

Caption

Purdue University researcher Mark Cushman serves as chief scientific officer, founder and board member for Gibson Oncology, a clinical-stage private pharmaceutical company. The company announced it has entered Phase 2 clinical trials for its treatment of first-time recurrent glioblastoma patients.

Credit

(Purdue University photo)

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.